Krohn Kai, Stanescu Ioana, Blazevic Vesna, Vesikari Timo, Ranki Annamari, Ustav Mart
Institute of Medical Technology, University of Tampere, Biokatu 8, 33520 Tampere, Finland.
Microbes Infect. 2005 Nov;7(14):1405-13. doi: 10.1016/j.micinf.2005.07.023. Epub 2005 Oct 4.
A potent DNA vaccine against HIV, combining a vector that takes advantage of the segregation and compartmentalization effect of bovine papilloma virus E2 protein with MultiHIV insert, expressing a fusion gene coding for the non-structural and structural proteins was developed and tested for immunogenicity in mice and humans.
一种针对HIV的高效DNA疫苗被研发出来,并在小鼠和人类身上测试了其免疫原性。该疫苗结合了一种利用牛乳头瘤病毒E2蛋白的分离和区室化效应的载体与MultiHIV插入片段,表达一种编码非结构蛋白和结构蛋白的融合基因。